Simvastatin Pretreatment Protects Cerebrum from Neuronal Injury by Decreasing the Expressions of Phosphor-CaMK II and AQP4 in Ischemic Stroke Rats

Overview

Journal J Mol Neurosci

Specialties Molecular Biology
Neurology

Date 2014 Apr 23

PMID 24752488

Citations 11

Authors

Min-Xia Zhu

Chao Lu

Chun-Mei Xia

Zhong-Wei Qiao

Da-Nian Zhu

Affiliations

Soon will be listed here.

Abstract

Excitotoxicity and cytotoxic edema are the two major factors resulting in neuronal injury during brain ischemia and reperfusion. Ca2+/calmodulin-dependent protein kinase II (CaMK II), the downstream signal molecular of N-methyl-D-aspartate receptors (NMDARs), is a mediator in the excitotoxicity. Aquaporin 4 (AQP4), expressed mainly in the brain, is an important aquaporin to control the flux of water. In a previous study, we had reported that pretreatment of simvastatin protected the cerebrum from ischemia and reperfusion injury by decreasing neurological deficit score and infarct area (Zhu et al. PLoS One 7:e51552, 2012). The present study used a middle cerebral artery occlusion (MCAO) model to further explore the pleiotropic effect of simvastatin via CaMK II and AQP4. The results showed that simvastatin reduced degenerated cells and brain edema while decreasing the protein expressions of phosphor-CaMK II and AQP4, and increasing the ratios of Bcl-2/Bax, which was independent of cholesterol-lowering effect. Immunocomplexes formed between the subunit of NMDARs-NR3A and AQP4 were detected for the first time. It was concluded that simvastatin could protect the cerebrum from neuronal excitotoxicity and cytotoxic edema by downregulating the expressions of phosphor-CaMK II and AQP4, and that the interaction between NR3A and AQP4 might provide the base for AQP4 involving in the signaling pathways mediated by NMDARs.

Citing Articles

Non-coding RNAs and Aquaporin 4: Their Role in the Pathogenesis of Neurological Disorders.

Yaghoobi Z, Seyed Bagher Nazeri S, Asadi A, Derafsh E, Taheri A, Tamtaji Z Neurochem Res. 2023; 49(3):583-596.

PMID: 38114727 DOI: 10.1007/s11064-023-04067-8.

Glutamate Neurotoxicity and Destruction of the Blood-Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies.

Gruenbaum B, Zlotnik A, Fleidervish I, Frenkel A, Boyko M Int J Mol Sci. 2022; 23(17).

PMID: 36077024 PMC: 9456007. DOI: 10.3390/ijms23179628.

Overlapping anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report.

Pan J, Ovlyakulov B, Zhou L Eur J Med Res. 2022; 27(1):66.

PMID: 35527314 PMC: 9082901. DOI: 10.1186/s40001-022-00697-w.

Statins in Neuro-ophthalmology.

Tan A, Fraser C, Khoo P, Watson S, Ooi K Neuroophthalmology. 2021; 45(4):219-237.

PMID: 34366510 PMC: 8312600. DOI: 10.1080/01658107.2020.1755872.

Effects of extracellular vesicles from mesenchymal stem cells on oxygen-glucose deprivation/reperfusion-induced neuronal injury.

Gu S, Kang X, Wang J, Guo X, Sun H, Jiang L World J Emerg Med. 2021; 12(1):61-67.

PMID: 33505552 PMC: 7790711. DOI: 10.5847/wjem.j.1920-8642.2021.01.010.

References

Yang B, Xiao C, Roa W, Krammer P, Hao C . Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J Biol Chem. 2002; 278(9):7043-50. DOI: 10.1074/jbc.M211278200. View

Yang G, Chen S, Kinouchi H, Chan P, Weinstein P . Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke. 1992; 23(9):1331-6. DOI: 10.1161/01.str.23.9.1331. View

Rodriguez-Yanez M, Agulla J, Rodriguez-Gonzalez R, Sobrino T, Castillo J . Statins and stroke. Ther Adv Cardiovasc Dis. 2009; 2(3):157-66. DOI: 10.1177/1753944708091776. View

Saadoun S, Papadopoulos M . Aquaporin-4 in brain and spinal cord oedema. Neuroscience. 2009; 168(4):1036-46. DOI: 10.1016/j.neuroscience.2009.08.019. View

Yang M, Gao F, Liu H, Yu W, Sun S . Temporal changes in expression of aquaporin-3, -4, -5 and -8 in rat brains after permanent focal cerebral ischemia. Brain Res. 2009; 1290:121-32. DOI: 10.1016/j.brainres.2009.07.018. View

Jung J, Bhat R, Preston G, Guggino W, Baraban J, Agre P . Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A. 1994; 91(26):13052-6. PMC: 45579. DOI: 10.1073/pnas.91.26.13052. View

Lee H, Choi S, Han E, Han K, Suh H . Role of glutamate receptors and an on-going protein synthesis in the regulation of phosphorylation of Ca2+/calmodulin-dependent protein kinase II in the CA3 hippocampal region in mice administered with kainic acid intracerebroventricularly. Neurosci Lett. 2003; 348(2):93-6. DOI: 10.1016/s0304-3940(03)00752-3. View

Colbran R, Smith M, Schworer C, FONG Y, Soderling T . Regulatory domain of calcium/calmodulin-dependent protein kinase II. Mechanism of inhibition and regulation by phosphorylation. J Biol Chem. 1989; 264(9):4800-4. View

Venero J, Vizuete M, Ilundain A, Machado A, Echevarria M, Cano J . Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience. 1999; 94(1):239-50. DOI: 10.1016/s0306-4522(99)00182-7. View

10.

Wayman G, Tokumitsu H, Davare M, Soderling T . Analysis of CaM-kinase signaling in cells. Cell Calcium. 2011; 50(1):1-8. PMC: 3236032. DOI: 10.1016/j.ceca.2011.02.007. View

11.

Yamauchi T . Neuronal Ca2+/calmodulin-dependent protein kinase II--discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull. 2005; 28(8):1342-54. DOI: 10.1248/bpb.28.1342. View

12.

Wright S, Schellenberger U, Ji L, Wang H, Larrick J . Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis. FASEB J. 1997; 11(11):843-9. DOI: 10.1096/fasebj.11.11.9285482. View

13.

Colbran R, Schworer C, Hashimoto Y, FONG Y, Rich D, Smith M . Calcium/calmodulin-dependent protein kinase II. Biochem J. 1989; 258(2):313-25. PMC: 1138364. DOI: 10.1042/bj2580313. View

14.

Sproul A, Steele S, Thai T, Yu S, Klein J, Sands J . N-methyl-D-aspartate receptor subunit NR3a expression and function in principal cells of the collecting duct. Am J Physiol Renal Physiol. 2011; 301(1):F44-54. PMC: 3129880. DOI: 10.1152/ajprenal.00666.2010. View

15.

Premkumar D, Mishra R, Overholt J, Simonson M, Cherniack N, Prabhakar N . L-type Ca(2+) channel activation regulates induction of c-fos transcription by hypoxia. J Appl Physiol (1985). 2000; 88(5):1898-906. DOI: 10.1152/jappl.2000.88.5.1898. View

16.

Miller S, Patton B, Kennedy M . Sequences of autophosphorylation sites in neuronal type II CaM kinase that control Ca2(+)-independent activity. Neuron. 1988; 1(7):593-604. DOI: 10.1016/0896-6273(88)90109-2. View

17.

Badaut J, Ashwal S, Tone B, Regli L, Tian H, Obenaus A . Temporal and regional evolution of aquaporin-4 expression and magnetic resonance imaging in a rat pup model of neonatal stroke. Pediatr Res. 2007; 62(3):248-54. DOI: 10.1203/PDR.0b013e3180db291b. View

18.

Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T . Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res. 2000; 78(1-2):131-7. DOI: 10.1016/s0169-328x(00)00084-x. View

19.

Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

20.

Balami J, Chen R, Grunwald I, Buchan A . Neurological complications of acute ischaemic stroke. Lancet Neurol. 2011; 10(4):357-71. DOI: 10.1016/S1474-4422(10)70313-6. View